Epidemiology of COVID-19 in Indonesia: common source and propagated source as a cause for outbreaks.

Isna Hikmawati,Ragil Setiyabudi

doi:10.3855/jidc.14240

Isna Hikmawati, Ragil Setiyabudi

Open Access

https://doi.org/10.3855/jidc.14240

Copy DOI

Abstract

The COVID-19 outbreak first occurred in China and has developed throughout the world, including Indonesia. The Indonesian government reports that up to May 22, 2020 there have been 21,430 confirmed cases. The purpose of this study is to describe the epidemiology, clinical symptoms and comorbidities of COVID-19 as well as the various government interventions to reduce the rate of incidence. A retrospective cohort study was designed. The population in this study is based data from the official Indonesian government website run by the Task Force for the Acceleration of Handling COVID-19. The sample was observed b March 2 to April 24, 2020. The total sample included 8,211 cases of patients diagnosed with COVID-19, among these 1,002 recovered and 689 died. Data analysis used percentages from various recorded epidemiological variables. The results showed that COVID-19 epidemiological features were mostly observed in men (56.5%) and patients of productive age (31-59 of age) by 57.5%; most deaths were recorded in patients aged > 60 years (43.6%). The most recurrent clinical symptom was cough (77.8%), the most recurrent comorbidity was hypertension (52.4%), and the province with the highest COVID-19 incidence was DKI Jakarta (34.3%). The combination of common sources and propagated source was observed during the COVID-19 outbreak in Indonesia. Special attention should be given to protecting vulnerable populations such as children, health care providers, and the elderly. The community is expected to participate in preventing the transmission of COVID-19 by complying with health protocols.

Highlights

The COVID-19 outbreak first occurred in China and has developed throughout the world, including Indonesia
University of Purwokerto, by Number: KEPK/UMP/15/VII/2020. The results of this COVID-19 epidemiological retrospective cohort study in Indonesia showed several epidemiological variables an overview of the COVID19 events is shown in Figure 1, with a higher percentage of male than female patients
The incidence of COVID-19 based on age classification, is shown in Figure 2, with following results: the highest mortality occurred at age > 60 years 43.6%, 46-59 years of age 40% and the lowest rate was observed in children and toddlers 0,7%

Summary

Introduction

The COVID-19 outbreak first occurred in China and has developed throughout the world, including Indonesia. The purpose of this study is to describe the epidemiology, clinical symptoms and comorbidities of COVID-19 as well as the various government interventions to reduce the rate of incidence. Hubai, China at the end of 2019, and almost the entire world reported cases in their respective countries. It was originally reported as a case of pneumonia caused by an unknown pathogen. The Indonesian government reported that as of May 22, 2020 21,430 cases were confirmed; of the latter, 14,413 people (69.3%) were under treatment, 5,057 people recovered (24.32%) and 1,326 people died (6.4%). The purpose of this study was to describe the epidemiology, clinical symptoms and comorbidities of COVID-19 patients as well as the various government interventions to reduce the rate of incidence

Objectives

Methods

Results

Discussion

Conclusion